The growth hormone (GH) receptor (GHR) binds GH in its extracellular domain and transduces activating signals via its cytoplasmic domain. Both GH-induced GHR dimerization and JAK2 tyrosine kinase activation are critical in initiation of GH signaling. We previously described a rapid GH-induced disulfide linkage of GHRs in human IM-9 cells. In this study, three GH-induced phenomena (GHR dimerization, GHR disulfide linkage, and enhanced GHR-JAK2 association) were examined biochemically and immunologically. By using the GH antagonist, G120K, and an antibody recognizing a dimerization-sensitive GHR epitope, we demonstrated that GH-induced GHR disulfide linkage reflects GH-induced GHR dimerization. GH, not G120K, promoted both GHR disulfide linkage and enhanced association with JAK2. Measures that diminished GH-dependent JAK2 and GHR tyrosine phosphorylation diminished neither GH-induced GHR disulfide linkage nor GH-enhanced GHR-JAK2 association. By using both transient and stable expression systems, we determined that cysteine 241 (an unpaired extracellular cysteine) was critical for GHinduced GHR disulfide linkage; however, GH-induced GHR dimerization, GHR-JAK2 interaction, and GHR, JAK2, and STAT5 tyrosine phosphorylation still proceeded when this cysteine residue was mutated. We conclude GH-induced GHR disulfide linkage is not required for GHR dimerization, and activation and GH-enhanced GHR-JAK2 association depends more on GHR dimerization than on GHR and/or JAK2 tyrosine phosphorylation.
The growth hormone receptor (GHR) 1 is a 620-residue transmembrane glycoprotein that binds GH in its extracellular domain and transduces activating signals via its cytoplasmic domain (1) (2) (3) . GH signals a variety of metabolic and somatogenic effects in multiple target tissues (4) . Because of conserved structural features in its extracellular domain, GHR is considered a member of the cytokine receptor superfamily, which includes receptors for prolactin, erythropoietin, and various interleukins and colony-stimulating factors, among others (5) . Many of these receptors also share common signaling features; most notably, they couple to members of the Janus family of cytoplasmic tyrosine kinases (JAKs) to initiate their signal cascades in response to ligand binding (6) . GHR couples in particular to JAK2 (7) .
The interaction of GH with the cell surface GHR is complicated but is now understood structurally with a high degree of resolution. Crystallographic and kinetic studies employing recombinant GH and GHR extracellular domain have elegantly demonstrated that GH interacts with the GHR to form a complex of 1:2 GH⅐GHR stoichiometry (8, 9) . Although GH is a molecule composed of four antiparallel helical bundles without an axis of symmetry, two distinct sites within each molecule of the hormone engage two GHR extracellular domains at nearly identical contact points on each receptor (9) . Binding of GH "site 1" to one GHR facilitates interaction of "site 2" with the second receptor (10) . The GH⅐GHR 2 complex is further stabilized by interaction between receptor dimer partners in the region of the GHR extracellular domain immediately proximal to the external face of the plasma membrane (9) . In addition, by using the human IM-9 lymphoblast that homologously expresses GHRs as a model system, we have detected a GH-dependent disulfide linkage of GHRs that is rapid and quantitatively significant (11) . Although the precise physiological role(s) of the disulfide linkage is enigmatic, a large fraction of GHRs activated by GH (as evidenced by tyrosine phosphorylation) undergo this linkage, and receptors becoming detergentinsoluble in response to GH are progressively accounted for by disulfide-linked GHRs (12) .
In contrast to the degree to which the extracellular interaction of the GHR with GH is known, the intracellular association of the receptor with its important signal transducer, JAK2, is only partly understood. Various lines of evidence indicate that physical interaction of the GHR and JAK2 is necessary for GH-induced JAK2 tyrosine kinase activation, tyrosine phosphorylation of JAK2, the GHR, and numerous signaling molecules and biological effects (Refs. 2 and 3 and references therein). Binding and functional assays demonstrate that within the GHR, the proline-rich Box 1 region (residues 279 -286) is necessary and the amino-terminal one-third of the cytoplasmic domain is sufficient for nearly full interaction with JAK2 (13) (14) (15) , and reciprocally, that regions of the amino terminus of JAK2 are required for association with the GHR (16, 17) . The GHR-JAK2 interaction can occur without GH occupancy of the GHR and can be detected in vitro without tyrosine phosphorylation of JAK2 or the GHR (15) ; however, GH treatment of cells augments the degree and/or strength of association of JAK2 with the GHR (7, 15, 18) . 2 Whereas this enhanced GHR-JAK2 association likely relates to GH-induced JAK2 signaling, the structural basis for this augmentation has yet to be intensively investigated.
In this communication, we biochemically and immunologically examine in several GHR-expressing cell lines the relationships between GH-induced GHR dimerization, GHR disulfide linkage, and GHR-JAK2 interaction. In so doing, we characterize several new reagents and refine the use of our existing tools and techniques to develop approaches to further study these proximal aspects of GH signaling. Our results indicate that GH-induced GHR disulfide linkage is detectable for murine and rabbit (as well as human) GHRs and can be detected in both non-adherent (IM-9) and adherent (3T3-F442A, COS-7, and CHO fibroblast) cell lines. GHR disulfide linkage as well as the loss of immunoprecipitability of GHRs with a new anti-GHR extracellular domain monoclonal antibody are shown to be useful reflectors of GH-induced GHR dimerization. Furthermore, we demonstrate that GH-induced enhancement of coimmunoprecipitation of JAK2 with anti-GHR serum directed at the receptor cytoplasmic domain is related to receptor dimerization, rather than receptor or JAK2 activation. Finally, by identifying an unpaired extracellular domain cysteine (residue 241) as critical to GH-induced GHR disulfide linkage, we differentiate noncovalent from disulfide-linked GHR dimerization, allowing us to compare these processes as they apply to the GHR with findings for other cytokine and growth factor receptors.
EXPERIMENTAL PROCEDURES
Materials-Recombinant hGH was kindly provided by Lilly. Recombinant hGH-G120K was kindly provided by Sensus Corp. (Austin, TX). Routine reagents were purchased from Sigma unless otherwise noted. Restriction endonucleases were obtained from New England Biolabs (Beverly, MA).
125 I-hGH (specific activity 85-130 Ci/g) was purchased from NEN Life Science Products.
Cells, Cell Culture, Transfections, and 125 I-hGH Binding-COS-7, IM-9, and 3T3-F442A (Ref. 19 ; a gift of Drs. H. Green (Harvard University) and C. Carter-Su (University of Michigan)) cells were maintained as described previously (12, 20) . COS-7 cells were transiently transfected at 75% confluency in 20 ml of DMEM in 150 ϫ 25-mm dishes (Falcon) by the calcium phosphate precipitation method (21) as described previously (15, 17) . Each dish was transfected with either 50 g of pSX rGHR, pSX rGHR C241S, pSX rGHR d297-406 , pSX rGHR d294 -498, or pSX rGHR , along with 25 g of pSX JAK2 (in some experiments), as indicated in the figure legends. For samples in which no exogenous GHR or JAK2 was expressed, pSX alone was added to equalize the amount of total DNA added in each transfection. Description of the pSX vector and construction of the plasmids used is found below. Serum starvation was begun at 24 h after transfection and continued for 16 -20 h prior to stimulation, harvesting, and detergent extraction, as below.
125
I-hGH binding capacity of COS-7 cells transiently expressing WT rGHR and rGHR C241S was assayed as described previously (15) .
CHO cells (a gift of Dr. J. Kudlow, University of Alabama, Birmingham) were maintained in DMEM (1 g/liter glucose) (Cellgro, Inc.) supplemented with 7% fetal bovine serum (Biofluids, Rockville, MD) and 50 mg/ml gentamicin sulfate, 100 units/ml penicillin, and 100 mg/ml streptomycin (all Biofluids). Stable transfection of CHO cells was achieved by introducing either pSX rGHR or pSX rGHR C241S (20 g of each in 3 ml of DMEM in 60 ϫ 15-mm dishes), each along with 1 g of pSP65-SR␣.2-HAtag-HygroHA-Hygro (empty vector carrying the hygromycin resistance marker, kindly provided by Dr. M. Streuli, Dana-Farber Cancer Institute, Boston), using Lipofectin (Life Technologies, Inc.) according to the manufacturer's protocol. Transfected cells were grown in complete DMEM growth medium for 48 h. After dilution, clones were negatively selected in medium supplemented with 500 g/ml hygromycin B (Roche Molecular Biochemicals) and screened for GHR expression by anti-GHR cyt-AL37 immunoblotting of detergent extracts, as in text and figure legends (untransfected CHO cells express no detectable GHR (13, 14) . 2 Antibodies-The 4G10 monoclonal antiphosphotyrosine (APT) antibody was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Anti-STAT5 monoclonal antibody was purchased from Transduction Laboratories (Lexington, KY). Anti-phospho-STAT5 affinity-purified rabbit polyclonal antibody (recognizing the tyrosine-phosphorylated form (Y694) of STAT5a and STAT5b) was purchased from Zymed Laboratories (San Francisco, CA).
The rabbit polyclonal sera, anti-GHR cyt (11) , directed at the residue 317-620 region of the human GHR cytoplasmic domain, and anti-GHR cyt-AL37 (18) , directed at residues 271-620 of the human GHR (the entire cytoplasmic domain), have been described. The anti-GHR cyt-mAb mouse monoclonal antibody (IgG2b) was also raised against a GST fusion protein incorporating residues 271-620 of the human GHR (15) and screened by enzyme-linked immunosorbent assay at the University of Alabama at Birmingham Multipurpose Arthritis Center Hybridoma Facility (Dr. M. Accaviti). Anti-GHR cyt-mAb reacted by enzyme-linked immunosorbent assay specifically with GST/hGHR 271-620 and not with GST. Similarly, immunoblotting of thrombin-cleaved GST/hGHR indicated that anti-GHR cyt-mAb reacted with hGHR 271-62 , but not with GST. The anti-GHR ext mouse monoclonal antibody (IgG1) (20, 22) , raised against a GST fusion protein incorporating residues 1-245 of the rabbit (r) GHR, has been described, as has the rabbit polyclonal serum, anti-JAK2 AL33 (18) , raised against residues 746 -1129 of murine JAK2 (23) . Anti-GHR cyt-mAb and anti-GHR ext were purified from ascites using the Affi-Gel Protein A MAPS II Kit (Bio-Rad), according to the manufacturer's suggestions.
Plasmid Construction-The pSX plasmid (a kind gift of Dr. J. Bonifacino, National Institutes of Health, and Dr. K. Arai, DNAX), which drives eukaryotic protein expression from the SR␣ promoter (composed of the SV40 early promoter and the R-U5 segment of the HTLV-1 long terminal repeat), has been described (20, 24) . Preparation of the rGHR cDNA (a kind gift of W. Wood, Genentech, Inc.) and the cDNAs encoding rGHR d297-406 (where subscript d indicates deletion) and rGHR and their ligation into pSX have been described (15, 17) . The cDNA encoding rGHR d294 -498 , with internal in-frame deletion of residues 294 -498, was the result of BsaB1 digestion and religation of the wild-type rGHR cDNA. The cDNA encoding rGHR C241S (changing the codon for residue 241 from cysteine to serine) was generated using the unique site elimination in vitro mutagenesis strategy (25) , unique site elimination mutagenesis kit by Amersham Pharmacia Biotech, according to the manufacturer's suggestions. Primer sequences are available upon request. Confirmation of the desired mutations and the absence of unwanted mutations in the cDNA constructs was accomplished by dideoxy DNA sequencing.
Cell Stimulation and Protein Extraction-Serum starvation of 3T3-F442A, IM-9, and transfected COS-7 and CHO cells was accomplished by substitution of 0.5% (w/v) bovine serum albumin (fraction V, Roche Molecular Biochemicals) for serum in their respective culture media for 16 -20 h prior to experiments. Unless otherwise noted, hGH was used at a final concentration of 500 ng/ml, and stimulations were performed at 37°C. Details of the hGH treatment protocol have been described (12, 20) . Briefly, for IM-9 cells, cells were stimulated in suspension at 10 million cells/ml in binding buffer (BB, consisting of 25 mM Tris-HCl (pH 7.4), 120 mM NaCl, 5 mM KCl, 1.2 mM MgCl 2 , 0.1% (w/v) bovine serum albumin, and 1 mM dextrose). Stimulations were terminated, and cells were collected by centrifugation (800 ϫ g for 1 min at 4°C) and aspiration of the BB. 3T3-F442A cells and transfected COS-7 cells were stimulated in confluent 150 ϫ 20-mm dishes (Falcon) in BB. Stimulations were terminated by washing the cells once with PBS and then harvesting by scraping in ice-cold PBS in the absence or presence (PBS/vanadate) of 0.4 mM sodium orthovanadate, as indicated in figure legends. Pelleted cells were collected by brief centrifugation. For each cell type, pelleted cells were solubilized for 15 min at 4°C in fusion lysis buffer (FLB) (1% (v/v) Triton X-100, 150 mM NaCl, 10% (v/v) glycerol, 50 mM Tris-HCl (pH 8.0), 100 mM NaF, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 10 mM benzamidine, 10 g/ml aprotinin), as indicated. After centrifugation at 15,000 ϫ g for 15 min at 4°C, the detergent extracts were either subjected to immunoprecipitation or were directly electrophoresed under nonreducing or reducing conditions, as indicated below. In the case of CHO-rGHR and CHO-rGHR C241S, harvested cells were in some experiments solubi-lized directly in reducing SDS-PAGE sample buffer, as indicated, prior to electrophoresis.
Immunoprecipitation, Electrophoresis, and Immunoblotting-For immunoprecipitation, the rabbit antisera described above were used at the following volumes per precipitation: anti-JAK2 AL33 , 3 l; anti-GH-R cyt-AL37 , 3 l. For immunoprecipitation of the GHR with the monoclonal anti-GHR ext and anti-GHR cyt-mAb antibodies, 0.6 g of purified antibody was used per precipitation. Protein A-Sepharose (Amersham Pharmacia Biotech) (or, for anti-GHR ext , protein G-Sepharose (Amersham Pharmacia Biotech)) was used to adsorb immune complexes, and after extensive washing with lysis buffer, SDS sample buffer eluates were resolved by SDS-PAGE and immunoblotted as indicated. Resolution of proteins under reducing or nonreducing conditions by SDS-PAGE, Western transfer of proteins, and blocking of Hybond-ECL (Amersham Pharmacia Biotech) with 2% bovine serum albumin were performed as described previously (12, 26) . Immunoblotting with antibodies 4G10 (1:2500), anti-phospho-STAT5 (1:1000), anti-GHR cyt-AL37 (1:2000) , anti-GHR cyt (1:2000) , or anti-JAK2 AL33 (1:2000) , with horseradish peroxidase-conjugated anti-mouse or anti-rabbit secondary antibodies (1:2000) and ECL detection reagents (all from Amersham Pharmacia Biotech) and stripping and reprobing of blots were accomplished according to manufacturer's suggestions.
Densitometric Analysis-Densitometry of ECL immunoblots was performed using a solid state video camera (Sony Ϫ77, Sony Corp.) and a 28-mm MicroNikkor lens over a light box of variable intensity (Northern Light Precision 890, Imaging Research Inc., Toronto, Canada). Quantification was performed using a Macintosh II-based image analysis program (Image 1.49, developed by W. S. Rasband, Research Services Branch, NIMH, Bethesda). In graphically displaying the fractional GH-induced loss of anti-GHR ext precipitation of GHRs (Fig. 7D , comparing WT rGHR and rGHR C241S), precipitability of GHRs for each condition was estimated by normalizing the densitometric signal for the GHR abundance in anti-GHR ext precipitates (detected by anti-GHR cyt blotting) by the densitometric signal for GHR abundance in the unprecipitated detergent extract resolved under reducing conditions (also detected by anti-GHR cyt blotting). This ratio for unstimulated samples was considered equal to 100% for each receptor (WT and CS mutant) in each of two separate experiments, as indicated.
Specific JAK2 tyrosine phosphorylation in COS-7 cells transiently expressing both GHR (WT rGHR or rGHR C241S) and JAK2 (Fig. 8B , lower panel) was estimated for each condition by normalizing the densitometric signal for tyrosine phosphorylation (APT immunoblot) of immunoprecipitated JAK2 by the abundance of JAK2 (anti-JAK2 AL33 immunoblot) in that precipitate. This ratio for unstimulated samples was considered equal to one for each receptor (WT and CS mutant). The fold increase in this ratio in response to GH is graphically displayed. Specific GHR tyrosine phosphorylation in the same COS-7 cell transfectants (Fig. 8C, upper panel) was estimated in the same fashion, except that precipitations were performed with anti-GHR cyt-AL37 , and anti-GHR immunoblotting of the precipitated GHRs was accomplished with anti-GHR cyt . Graphical assessment of coimmunoprecipitation of JAK2 with anti-GHR cyt-AL37 for each condition in the same COS-7 cell transfectants (Fig. 8C, lower panel) was accomplished by normalizing the densitometrically determined abundance of JAK2 (anti-JAK2 AL33 immunoblot) in anti-GHR cyt-AL37 precipitates by both the densitometrically determined abundance of GHR (anti-GHR cyt immunoblot) in the same precipitates and the total JAK2 abundance (anti-JAK2 AL33 immunoblot of anti-JAK2 AL33 precipitates). This ratio for unstimulated samples was considered equal to one for each receptor (WT and CS mutant), and the fold increase in this ratio in response to GH is graphically displayed.
RESULTS

GH-induced Loss of Anti-GHR ext Immunoprecipitability
Correlates to GH-induced GHR Dimerization-Initial experiments focused on more detailed characterization of our recently described (20, 22) mouse monoclonal antibody against the rabbit GHR extracellular domain, anti-GHR ext . Although it is only minimally capable of immunoblotting (data not shown), anti-GHR ext , as previously reported (22) , can specifically recognize the human (h) GHR by immunoprecipitation. We noticed during this early characterization, however, that GH treatment of cells rendered the GHR less immunoprecipitable by anti-GH-R ext (Fig. 1) . IM-9 lymphoblasts were treated with GH or vehicle for 10 min at 37°C prior to detergent lysis. Extracts were subjected to immunoprecipitation with anti-GHR cyt-AL37 (a rabbit polyclonal serum directed at the GHR cytoplasmic domain (18) ), nonimmune rabbit serum (a negative control), anti-GH-R cyt-mAb (a mouse monoclonal antibody directed at the GHR cytoplasmic domain), or anti-GHR ext . Eluates of these precipitates (upper panel) as well as nonprecipitated detergent extracts (middle panel) were resolved under reducing conditions by SDS-PAGE, and GHRs present in each sample were immunoblotted with anti-GHR cyt (an independently derived rabbit polyclonal serum directed at the receptor cytoplasmic domain (11)). Whereas GH treatment did not affect the abundance of GHRs detectable in either the extracts (middle panel, lanes [1] [2] [3] [4] [5] [6] [7] [8] or the specific anti-GHR cyt-AL37 or anti-GHR cyt-mAb precipitates (upper panel, lanes [3] [4] [5] [6] , notably less GHR was detected in the anti-GHR ext precipitate from GH-treated cells than in the precipitate from cells not exposed to GH (upper
panel, lane 8 versus lane 7).
In principle, this GH-induced loss of anti-GHR ext precipitability could be accounted for by any of three potential possibilities as follows: 1) GH induces a loss of GHRs from the detergent-soluble extract such that less receptors are available for immunoprecipitation; 2) GH binding directly interferes with the epitope(s) in the extracellular domain of the GHR that are recognized by anti-GHR ext ; 3) GH, by promoting dimerization of GHRs, promotes interference of the interaction of anti-GH-R ext with dimerization-sensitive epitope(s) in the GHR extracellular domain and thus results in less immunoprecipitation of GHRs. In our previous studies, we have observed GH-induced loss of detergent-soluble GHRs and corresponding accumulation of detergent-insoluble GHRs in IM-9 cells (12) . However, the GH-induced loss of anti-GHR ext immunoprecipitability that we now observe is not likely to be explained by such a change in detergent solubility since the abundance of GHRs detectable in both unprecipitated detergent extracts and anti-GHR cyt-AL37 precipitates does not vary with the 10-min GH treatment at 37°C. This is consistent with our previous finding that significant loss of detergent-soluble GHRs was difficult to observe when GH stimulation was for less than 30 min at 37°C (12) . In addition, in other experiments (not shown), GH-induced loss of anti-GHR ext immunoprecipitability was observed even when cells were treated with GH at 4°C; no GH-induced loss of GHR detergent solubility was detectable in our previous studies under these conditions (12) .
To address the other two possibilities for the GH-induced loss of anti-GHR ext precipitability of the GHR (GH blockade of the epitope(s) versus GHR dimerization-sensitive blockade of the epitope(s)), we used an hGH analog, G120K, with a mutation at residue 120 (glycine to lysine); this mutation results in elimination of its binding to the GHR at site 2 but preserves site 1 interaction. G120K is thus able to bind to the GHR but is unable to dimerize GHRs; similarly, this type of point mutated GH functions as a GH antagonist in that by competition for site 1 binding it inhibits the ability of normal GH to promote GHR dimerization (10, 27) . As seen in Fig. 2A , treatment of IM-9 cells with G120K alone, unlike treatment with GH, had no effect on the ability of anti-GHR ext to immunoprecipitate the GHR (upper panel, lanes [1] [2] [3] . Furthermore, the GH-induced loss of anti-GHR ext precipitability was reversed when G120K was added with GH at a ratio of G120K:GH equal to 2:1 (Fig. 2B , upper panel, lanes [1] [2] [3] [4] . The antagonism of G120K to the ability of GH to inhibit anti-GHR ext precipitability indicates that the G120K was, as expected, able to bind to the GHR in these cells. This G120K antagonism, coupled with the inability of G120K to alone inhibit anti-GHR ext precipitability, indicates that the loss of anti-GHR ext precipitability in response to GH is correlated with hormone-induced GHR dimerization, rather than with GH binding to the GHR. Furthermore, these results suggest that GH-induced loss of anti-GHR ext immunoprecipitability can be used to monitor GH-induced GHR dimerization.
GHR Dimerization Is Correlated with GHR Disulfide Linkage-We have previously described GH-induced disulfide linkage of GHRs that occurs even at 4°C and have noted that roughly one-half of GHRs undergoing tyrosine phosphorylation rapidly in response to GH at 37°C exist in this disulfide-linked form (11, 12) . Furthermore, GHRs that accumulate in the detergent-insoluble fraction of IM-9 cells in response to GH are enriched in this disulfide-linked form (12) . This GH-induced formation of the disulfide-linked GHR was again demonstrated in the present study by resolving detergent extracts of untreated and GH-treated cells by SDS-PAGE under nonreducing conditions and detecting monomeric and disulfide-linked GHRs by immunoblotting with anti-GHR cyt ( Fig. 1 , lower panel, lanes [1] [2] [3] [4] [5] [6] [7] [8] . By using the information derived from the experiments described above in the upper panels of Figs. 1 and 2, we tested whether GH-induced disulfide linkage such as that shown in the lower panel of Fig. 1 might reflect GH-induced GHR dimerization.
As a first step in rigorously probing the relationship between GH-induced GHR disulfide linkage and GHR dimerization, we tested the effect of the non-dimerizing G120K antagonist on receptor disulfide linkage. As seen in Fig. 2A (lower panel) , treatment of IM-9 cells with G120K did not promote appearance of the disulfide-linked GHR (lane 3 versus lane 2). Furthermore, in a pattern that mirrored its ability to inhibit GHinduced loss of anti-GHR ext immunoprecipitability, G120K significantly antagonized GH-induced GHR disulfide linkage with nearly complete inhibition at a G120K:GH ratio of 2:1 (Fig. 2B, lower panel, lanes 2-4) . Thus, the capacity of GH to dimerize GHRs appears to be required to cause GHR disulfide linkage.
This point was further verified by comparing the GH concentration dependence of the two phenomena (loss of anti-GHR ext precipitability and GHR disulfide linkage). IM-9 cells were either left unstimulated or treated with GH (1-500 ng/ml in Fig. 3A ; 500 -8000 ng/ml in Fig. 3B ) for 10 min at 37°C. Detergent extracts were either immunoprecipitated with anti-GHR ext and resolved under reducing conditions (upper panels) or directly resolved without immunoprecipitation under reducing conditions (middle panels) or nonreducing conditions (lower panels) by SDS-PAGE. GHRs in each instance were detected by immunoblotting with anti-GHR cyt (Fig. 3A) or anti-GHR cyt-AL37 (Fig. 3B) . Notably, the GH concentration dependence of the loss of anti-GHR ext immunoprecipitability (which reflects GHR dimerization, as shown above in Figs. 1 and 2 ) and the appearance of the disulfide-linked GHR were quite similar in both the 1-500 and 500 -8000 ng/ml ranges. In particular, both the GH-induced loss of anti-GHR ext precipitability and the GHinduced accumulation of disulfide-linked GHRs were attenuated at GH concentrations of 2000 -8000 ng/ml compared with 500 ng/ml (Fig. 3B, lanes 3-5 versus lane 2) . Such a suppression of these two GH-induced changes at very high GH concentrations (which is concert with our previous findings for the disulfide linkage (11)) is consistent with dimerization dependence of both (8) . Together, the results of the experiments shown in Figs. 2 (lower panels) and 3 clearly indicate the correlation between GH-induced GHR dimerization and accumulation of the disulfide-linked form of the receptor.
While GHR dimerization is believed to be a critical step in GH signaling (10) , detailed understanding of the relationship between the dimerization state of the receptor and its capacity to interact with key intracellular signaling molecules does not yet exist, nor do we yet know the structural basis for the impact of GHR dimerization on GH signaling. In part, the difficulty in fully understanding these issues is in biochemically assessing GHR dimerization in cells under the usual conditions employed in protein extraction, immunoprecipitation, and SDS-PAGE. Our observations that both GHR disulfide linkage and loss of anti-GHR ext precipitability reflect the dimerization state of the receptor are of potential utility in that assessments of each process might serve as relatively simple biochemical proxies for GHR dimerization.
GH-induced Enhancement of Association of JAK2 with the GHR Is Related to the Dimerization State of the Receptor-One
interaction critical for effective GH signaling, but incompletely understood, is between the GHR and the cytoplasmic tyrosine kinase, JAK2 (7, (13) (14) (15) . The bacterially expressed cytoplasmic domain of the GHR can interact in vitro via its Box 1 region with JAK2 derived from cells not treated with GH prior to extraction (15) . Similarly, basal (GH-independent) association of JAK2 with the GHR can be detected in extracts of cells that express both molecules (15); however, our work and that of others (7, 15, 20) 2 indicate that treatment of cells with GH enhances the association of the GHR and JAK2, as assessed by coimmunoprecipitation of JAK2 with various anti-GHR antibodies. This effect is pronounced in the highly GH-responsive murine 3T3-F442A fibroblast cell line (7, 20) . We explored the mechanism of this GH-dependent enhancement of GHR-JAK2 association in this cell type. We first tested the effect of G120K versus GH on GHR dimerization status and GHR-JAK2 association (Fig. 4) . In preliminary experiments (not shown), we determined that anti-GHR ext did not detect the murine GHR by either immunoprecipitation or immunoblotting; thus, we could not use this antibody to probe the dimerization state of the endogenous GHR in mouse cells. However, as with IM-9 cells, treatment of 3T3-F442A cells with GH did promote appearance of the disulfidelinked form of the GHR (Fig. 4A, lane 2 versus 1) , confirming that this change in the GHR can be detected for murine as well as human receptors (as shown below, GH-induced disulfide linkage occurs with the rabbit GHR as well). Also similar to our findings in IM-9 cells, treatment with G120K alone could not support GHR disulfide linkage; however, when added with GH at a G120K:GH ratio of 5:1, G120K inhibited GH-induced GHR disulfide linkage (Fig. 4A, lanes 3 and 4 versus 2) . In other experiments, a G120K:GH ratio of 3:1 was sufficient to inhibit GH-induced GHR disulfide linkage (not shown). Thus, in 3T3-F442A cells, disulfide linkage (a structural correlate of receptor dimerization) displays similar sensitivity to the GH antagonist as it does in IM-9 cells.
We next examined the coimmunoprecipitation of JAK2 with the GHR in 3T3-F442A cells. For this purpose, we employed anti-GHR cyt-AL37 as the immunoprecipitating antibody. As seen in Fig. 4B , when assessed by immunoblotting with anti-GHRcyt , the 3T3-F442A GHR was specifically precipitated by anti-GHR cyt-AL37 to a similar degree from detergent extracts of unstimulated cells and cells treated with GH, G120K, or the combination of GH and G120K (lanes 1-4, upper panel) . Despite this similarity in the abundance of directly precipitated GHR, GH treatment, as anticipated, promoted a marked enhancement in JAK2 coimmunoprecipitated with anti-GHR cyt-AL37, as assessed by reprobing of the blot with anti-JAK2 AL33 (Fig. 4B, lower panel, lane 2 versus 1) . Notably, G120K alone promoted no such augmented association of JAK2 with the GHR (lane 3) but effectively competed away GH-induced coprecipitation of JAK2 with the receptor (lane 4).
These differences in coimmunoprecipitation of JAK2 with the GHR were not accounted for by differences in the abundance of JAK2 present in each extract, as confirmed by immunoprecipitation of the same extracts with anti-JAK2 AL33 followed by immunoblotting of JAK2 (Fig. 4C, upper panel, lanes  1-4) . Similar to these findings regarding GHR disulfide linkage and association of JAK2 with the GHR, G120K also failed to promote tyrosine phosphorylation of JAK2 such as that detected in response to GH in both anti-JAK2 AL33 direct precipitates and anti-GHR cyt-AL37 coprecipitates. However, G120K did substantially antagonize GH-induced JAK2 tyrosine phosphorylation (Fig. 4C, middle and lower panels, lanes 1-4) .
The results of the experiments in Fig. 4 indicate that in 3T3-F442A cells GH-induced GHR dimerization (conveniently monitored by tracking GHR disulfide linkage) is required for both JAK2 tyrosine phosphorylation and JAK2's association with the receptor. These experiments did not, however, address the question of whether tyrosine phosphorylation of the GHR and/or JAK2 is required to support the GH-enhanced coimmunoprecipitation of JAK2 with the GHR. In other words, is it the GHR dimerization that fosters enhanced GHR-JAK2 association or is it the JAK2 activation and tyrosine phosphorylation of the GHR and JAK2 that result from GHR dimerization that allow enhanced GHR-JAK2 association? We pursued this issue in two ways. First, we tested whether the degree to which preservation of the GH-induced tyrosine phosphorylation of JAK2 and the GHR during the processing and extraction of the cells affected the abundance of JAK2 coimmunoprecipitated with the GHR. In preliminary experiments (not shown), we observed that GHinduced tyrosine phosphorylation of the GHR, JAK2, and other substrates was significantly more detectable after detergent extraction, SDS-PAGE, and APT immunoblotting if the GHtreated cells were washed prior to harvesting and lysis with ice-cold PBS that contained sodium orthovanadate. Inclusion of orthovanadate in the cell wash and harvesting buffer presumably better "traps" proteins in their tyrosine-phosphorylated state by inhibiting cellular protein tyrosine phosphatases that are either always active or are adventitiously activated during harvesting and collection of the cells.
In the experiment shown in Fig. 5 , 3T3-F442A cells were treated in duplicate with (ϩ) or without (Ϫ) GH for 15 min and then harvested and collected in PBS that either contained (ϩ) or did not contain (Ϫ) sodium orthovanadate (0.4 mM). In all samples, cells were lysed in the standard lysis buffer that contained sodium orthovanadate and under the usual solubilization conditions (as under "Experimental Procedures"). Immunoprecipitation with anti-GHR cyt-AL37 followed by SDS-PAGE and immunoblotting with anti-JAK2 AL-33 revealed that inclusion of orthovanadate in the cell wash and harvesting buffer had no effect on the degree to which GH treatment promoted coimmunoprecipitation of JAK2 with the GHR (upper panel, lane 4 versus lane 2). However, as anticipated, stripping and reprobing of this blot with APT antibody revealed that the degree to which the directly precipitated GHR and coprecipitated JAK2 were detectably tyrosine-phosphorylated was markedly diminished when orthovanadate was omitted from the buffer (lower panel, lane 4 versus lane 2) . (We verified in other experiments (not shown) that inclusion of orthovanadate in the wash and harvesting buffer had no effect on the abundance of JAK2 or GHR present in the cell extracts or in direct immunoprecipitates of each.) This result indicates that differential degrees of preservation of GH-induced tyrosine phosphorylation of GHR and JAK2 do not affect the stability of the GH-induced enhanced interaction of the GHR and JAK2, as assessed by coimmunoprecipitation.
We further addressed the issue of whether GHR dimerization versus the consequent tyrosine phosphorylations were responsible for enhanced GHR-JAK2 association by attempting to uncouple the two phenomena. We have previously observed in IM-9 cells that GH-induced GHR disulfide linkage was not affected by pretreatment of the cells with staurosporine but that GH-induced tyrosine phosphorylation of cellular proteins was markedly blunted under the same conditions (11) . In the experiment shown in Fig. 6 , 3T3-F442A cells were treated with GH either in the presence or absence of staurosporine (1.25 M). Anti-GHR cyt immunoblotting of detergent extracts subjected to SDS-PAGE under nonreducing (Fig. 6A, upper panel) or reducing (Fig. 6A, lower panel) conditions confirmed that, as in IM-9 cells, staurosporine pretreatment did not affect either the degree of GH-induced GHR disulfide linkage or the GHR abundance in these cells (lane 3 versus lane 2 in each panel). Staurosporine pretreatment, however, significantly blunted the degree of GH-induced tyrosine phosphorylation of JAK2, as assessed by anti-JAK2 AL33 immunoprecipitation and APT immunoblotting (Fig. 6B, upper panel, lane 3 versus lane 2) without affecting the abundance of the JAK2 that was immunoprecipitated (Fig. 6B, lower panel, lane 3 versus lane 2) . Similarly, when the same extracts were immunoprecipitated with anti-GHR cyt-AL37 , the level of GH-induced tyrosine phosphorylation of both directly precipitated GHR and coimmunoprecipitated JAK2 was also markedly diminished by staurosporine pretreatment (Fig. 6C, upper panel, lane 3 versus lane 2) . Notably, despite the diminished GH-induced JAK2 tyrosine phosphorylation, staurosporine pretreatment did not affect the abundance of JAK2 coimmunoprecipitated with the GHR in response to GH (Fig. 6C, lower panel, lane 3 versus lane 2) . This result complements the findings displayed in Fig. 5 ; collectively, they indicate that the GH-enhanced association of JAK2 with the GHR is related more to GHR dimerization, per se, than to consequent JAK2 and/or GHR tyrosine phosphorylation.
GHR Disulfide Linkage Involves Cysteine 241 and Is Not Required for GHR Dimerization-
The above results indicated that GH-induced GHR disulfide linkage correlates with GHR dimerization and that receptor dimerization allows enhanced association of the GHR and JAK2 and is required for effective signaling. It therefore became relevant to ask whether disulfide linkage is required for GHR dimerization and consequent GHR-JAK2 association and signaling. To address this issue, we sought to abrogate GH-induced disulfide linkage by mutation of relevant receptor cysteine residue(s) that might be involved in such a linkage. It is known from both mutagenic and crystallographic studies that there are six cysteine residues conserved in the GHR extracellular domains of various species that are engaged in three pairs of intrachain disulfide linkages (9); these linkages are critical to the structural integrity of receptor independent of its occupancy by GH and would thus not be predicted to be candidates for participating in GHinduced GHR disulfide linkage. The remaining cysteine residues in the rGHR are indicated in the diagram of the receptor in Fig. 7A . Without any prior information, we presumed each of these remaining cysteines (residue 241 in the extracellular domain and residues 371, 387, 407, 496, 506, 518, 525, and 607 in the cytoplasmic domain) could be unpaired and thus a candidate for being involved in the GH-induced disulfide linkage (all but cysteine 387 are conserved in the human GHR).
Because of the relatively reducing intracellular environment, we thought it unlikely that such a linkage would be favored to occur via the cytoplasmic domain. Nevertheless, in preliminary experiments, we evaluated the ability of several of our previously characterized rGHR mutants (see Fig. 7A ) to undergo GH-induced GHR disulfide linkage when transiently expressed in COS-7 cells. These experiments indicated that rGHR mutants harboring either internal deletions of residues 297-406 (eliminating cysteines 371 and 387) or 294 -498 (eliminating cysteines 371, 387, 407, and 496) or carboxyl-terminal truncation of residues 391-620 (eliminating cysteines 407, 496, 506, 518, 525, and 607) were each capable of undergoing GHinduced GHR disulfide linkage (data not shown). Thus, none of the cysteine residues present in the rGHR cytoplasmic domain could be experimentally implicated as involved in the disulfide linkage. We therefore mutated the only remaining unpaired extracellular cysteine residue (cysteine 241) to serine and compared the capacity of the resulting mutant, designated rGHR C241S (diagrammed in Fig. 7A) , and the wild-type (WT) rGHR to undergo GH-induced disulfide linkage.
Expression vectors with the cDNAs encoding WT rGHR and rGHR C241S were transiently expressed in COS-7 cells. As assessed by anti-GHR cyt immunoblotting of reduced cell extracts (Fig. 7B, upper panel) and by 125 I-hGH binding studies (not shown), both WT and C241S receptors were similarly detectable and capable of binding to GH. To test for disulfide linkage, transfected cells were treated without (Ϫ) or with (ϩ) GH for 10 min, and detergent extracts of the cells were subjected to SDS-PAGE under nonreducing conditions and immunoblotted with anti-GHR cyt-AL37 (Fig. 7B, lower 
panel). GHinduced appearance of the disulfide-linked receptor form was detected for the WT rGHR (lane 3 versus lane 2) but not for rGHR C241S (lane 5 versus lane 4).
We also tested whether the C241S mutant, despite its inability to undergo GH-induced disulfide linkage, exhibited evidence of GH-induced dimerization. For this, we employed anti-GHR ext for immunoprecipitation of aliquots of the same extracts analyzed in Fig. 7B . For both WT rGHR and rGHR C241S, there was a substantial loss of receptors precipitated by anti-GHR ext after treatment of the cells with GH (Fig. 7C,  upper panel, lanes 2-5) . When the results of two such experiments were subjected to densitometric analysis and normalized for the GHR expression level in each extract, GHRs precipitated by anti-GHR ext fell in abundance on average by 86% for WT rGHR and 48% for rGHR C241S in response to GH (Fig.  7D ). This substantial GH-induced loss of anti-GHR ext precipitability of both WT rGHR and rGHR C241S strongly suggests that each underwent GH-induced receptor dimerization, although dimer formation and/or stability were likely more significant for the WT rGHR. Mutation of cysteine 241, therefore, abrogates GH-induced GHR disulfide linkage but not GH-induced receptor dimerization.
We further examined the effect of mutation of cysteine 241 on GH-induced signaling and enhancement of GHR-JAK2 association in both transiently and stably transfected cells. Our previous studies indicated that transient cotransfection of COS-7 cells with JAK2 and the GHR allowed detection of GH-dependent JAK2 tyrosine phosphorylation (15, 17) . In the experiment shown in Fig. 8 , cells were transiently transfected with expression vectors encoding murine JAK2 and either WT rGHR (lanes 2, 3, and 6 ) or rGHR C241S (lanes 4 and 5) . As a negative control, empty vector alone was transfected (lane 1). Transfected cells were treated without (Ϫ) or with (ϩ) GH for 10 min. Anti-GHR cyt immunoblotting of detergent extracts of each sample resolved under reducing (Fig. 8A, upper panel) and nonreducing (Fig. 8A, lower panel) conditions again verified similarity of expression of each receptor and the inability of rGHR C241S to undergo GH-induced receptor disulfide linkage. Notably, GH induced a subtle, but discernible, retardation of migration of the monomeric WT and C241S rGHRs, both under reducing and nonreducing conditions (compare lanes 3 and 6 versus lane 2 and lane 5 versus lane 4 in both upper and lower panels). This shift is consistent with both WT rGHR and FIG. 7. Cysteine 241 is critical for GH-induced disulfide linkage, but not GH-induced dimerization, of the rabbit GHR. A, diagram of the structure of WT rGHR and rGHR mutants used in experiments in Figs. 7 and 8 and in data not shown. rGHR mutants (rGHR C241S, rGHR d297-406 , rGHR d294 -498 , and rGHR 1-390 ) are described under "Experimental Procedures" and "Results." The positions of the extracellular, transmembrane (white space), and intracellular domains are indicated, as are the unpaired cysteine residues referred to in the text. Results of experiments in B and in data not shown are summarized with ϩ or Ϫ to indicate whether GH can or cannot, respectively, promote disulfide linkage of the rGHR form shown. B, WT rGHR, but not rGHR C241S, transiently expressed in COS-7 cells, undergoes disulfide linkage in response to GH. Transient transfections of COS-7 cells with expression vectors encoding WT rGHR or rGHR C241S (or empty vector as a negative control) were accomplished as under "Experimental Procedures." Cells were treated without (Ϫ) or with (ϩ) GH (500 ng/ml) for 10 min. FLB extracts (one-fourth 150 ϫ 25-mm dish equivalent per condition) were resolved by SDS-PAGE under reducing (upper panel) or nonreducing (lower panel) conditions. GHRs were detected by anti-GHR cyt or anti-GHR cyt-AL37 immunoblotting (WB), as indicated. The positions of the monomeric and disulfide-linked (dsl) rabbit GHR are bracketed. The large band (bracketed and marked NS) migrating just below the monomeric GHR in the lower panel is a mixture of the underglycosylated GHR and a comigrating nonspecific band uniquely recognized by anti-GHR cyt-AL37 immunoblotting (Y. Zhang, J. Jiang, and S. J. Frank, unpublished observations). C, rGHR C241S, although incapable of undergoing GH-induced disulfide linkage, is, like WT rGHR, rendered markedly less precipitable by anti-GHR ext in response to GH. COS-7 cells were transfected and treated as in B. FLB extracts (one 150 ϫ 25-mm dish equivalent per condition) were immunoprecipitated (IP) with anti-GHR ext , and eluates were resolved by SDS-PAGE under reducing conditions. GHRs were detected by anti-GHR cyt immunoblotting. D, anti-GHR ext precipitability of WT rGHR and rGHR C241S was assessed densitometrically, as detailed under "Experimental Procedures," from two separate experiments such as that shown in C. Average GH-induced loss of anti-GHR ext precipitation for each receptor form is graphically displayed (error bars are range about the mean in two independent experiments).
rGHR C241S undergoing GH-induced receptor tyrosine phosphorylation (more below).
These same extracts were immunoprecipitated with anti-JAK2 AL33 , and as a negative control, the extract from a duplicate pool of cells transfected with JAK2 and WT rGHR and stimulated with GH was precipitated with nonimmune serum (lane 6). Anti-JAK2 AL33 immunoblotting of these precipitates (Fig. 8B, upper panel) showed that the transfected JAK2 was similarly abundant in the transfected cells (lanes 2-5) , was specifically precipitated by anti-JAK2 AL33 (lane 6 versus lanes [2] [3] [4] [5] , and was much more abundant than the endogenous COS-7 JAK2 (lane 1 versus lanes 2-5) . Stripping and reprobing of this blot with APT antibody revealed that both WT rGHR and rGHR C241S mediated GH-induced tyrosine phosphorylation of JAK2 (Fig. 8B, middle panel, Fig. 8B, lower panel) .
Anti-GHR cyt-AL37 immunoprecipitation was also performed on extracts of these transiently transfected cells. Densitometric analysis of APT and anti-GHR cyt immunoblots of the precipitated receptors verified the conclusions suggested by the retarded migration of GHRs described above in that similar degrees of relative GH-induced GHR tyrosine phosphorylation were seen for specifically precipitated WT rGHR and rGHR C241S (Fig. 8C, upper panel) . When anti-JAK2 AL33 immunoblotting of JAK2 coprecipitated with anti-GHR cyt-AL37 was examined, GH-induced association of JAK2 with the GHR was also detected for both receptors (Fig. 8C, lower panel) . Collectively, the results of the transient transfection experiments shown in Figs. 7 and 8 lead us to conclude that GH-induced GHR dimerization, rather than receptor disulfide linkage, is required for GHR-JAK2 association and JAK2 and GHR tyrosine phosphorylation.
To verify and extend these findings in a system in which GHRs are stably reconstituted, we used Chinese hamster ovary (CHO) cells, which others have shown to express no endogenous GHRs and to be a useful vehicle for GHR expression and studies of GH signaling (13, 14) . CHO cells were stably transfected with WT rGHR or rGHR C241S, as under "Experimental Procedures"; two clones, designated CHO-rGHR (expressing WT rGHR) and CHO-rGHR C241S (expressing rGHR C241S), were selected for further evaluation based on their similar levels of receptors detected by immunoblotting (as shown in Also as observed in transient reconstitution experiments, GH promoted enhanced coimmunoprecipitation of JAK2 with anti-GHR cyt-AL37 in both CHO-rGHR and CHO-rGHR C241S cells (Fig. 9B, lower panel) , and GHR and JAK2 both became tyrosine-phosphorylated acutely in response to GH in each cell line (data not shown). To monitor further the ability of GH to acutely activate signaling via the WT and C241S mutant receptors, we examined the tyrosine phosphorylation of STAT5 in response to GH in CHO-rGHR and CHO-rGHR C241S (Fig.  9C ). Since levels of STAT5 did not vary between the two cell lines (data not shown), we used a state-specific antibody, antiphospho-STAT5, which detects only the tyrosine-phosphorylated form of STAT5, to compare by immunoblotting of total cell extracts the time course (Fig. 9C, upper panel) and GH concentration dependence (Fig. 9C, lower panel) of STAT5 activation in each cell. The time course of GH-induced STAT5 tyrosine phosphorylation was indistinguishable between the two cells with detection as early as 1 min into GH stimulation in both CHO-rGHR and CHO-rGHR C241S. Likewise, the concentration dependence for STAT5 tyrosine phosphorylation after 10 min exposure to GH was the same for both cells with detectable signal evident in response to as little as 10 ng/ml GH and maximal with 100 -250 ng/ml GH. Thus, using both transient and stable transfection, no substantial difference was observed in the ability of GH to dimerize acutely the GHRs or to initiate proximal aspects of GHR signaling in cells expressing the wildtype versus C241S mutant GHR.
DISCUSSION
It is generally appreciated that GH-induced dimerization of the GHR is important for GH signaling. Many molecular details of the GH-GHR interaction are understood structurally, but less is known about the dimerization process as it occurs in cells and the effects of receptor dimerization on the association of GHR with intracellular signaling molecules. These issues are intrinsically difficult to study biochemically in part because the standard immunological and electrophoretic techniques useful in studies of signaling typically promote denaturation and disassembly of noncovalently dimerized receptors and proteins with which they interact. In this study, we develop two tools for biochemically tracking GH-induced receptor dimerization, GH-induced loss of anti-GHR ext precipitation and assessment of GH-induced disulfide linkage of the GHR, and we make use of these and other reagents we have developed to examine further both structural aspects of receptor dimerization and determinants for GHR-JAK2 interaction.
Anti-GHR ext monoclonal antibody was raised against the rabbit GHR extracellular domain and can effectively immunoprecipitate rabbit, human, and bovine (data not shown) GHRs; it does not significantly recognize murine or rat receptors (data not shown). We found that GH treatment of cells that express the rabbit or human GHRs led to a significant loss of immunoprecipitability of the receptors with anti-GHR ext , a characteristic not shared by three separate antibodies (data for one of them, anti-GHR cyt , not shown in this study) directed at the cytoplasmic domain of the receptor. The GH antagonist, G120K, while it could bind to the GHR (as evidenced by its ability to compete with GH for GH-dependent effects), did not render the GHR less precipitable by anti-GHR ext . Thus, the ability of anti-GHR ext to recognize the GHR depends on the dimerization state of the receptor, rather than its state of ligand occupancy. Although we do not yet know whether this loss of recognition by anti-GHR ext is related to a conformational change occurring within receptor monomers upon their dimerization or whether it is because of dimerization-induced blockade of an epitope located in what becomes the GHR-GHR interface, testing of the ability of this antibody to immunoprecipitate the receptor appears a convenient means of immunologically and electrophoretically assessing the degree of GHR dimerization.
We previously detected and partially characterized GH-induced GHR disulfide linkage in human IM-9 lymphoblasts (11, 12) , cells that homologously express roughly 5000 GH-binding sites per cell (28) . In those cells, GH treatment induces rapid formation of a species migrating in nonreducing SDS-PAGE at roughly 215-230 kDa that reacts with several independently derived antisera directed at the GHR cytoplasmic domain. In our earlier studies, two-dimensional nonreducing/reducing "diagonal" SDS-PAGE revealed that this 215-230-kDa species, when reduced, contained the monomeric GHR and was therefore suspected of representing a dimerized GHR that under-went disulfide linkage (11) . Furthermore, a substantial fraction of the GHRs undergoing acute GH-induced tyrosine phosphorylation were found in the disulfide-linked form, although GHR disulfide linkage occurred even if GH-induced tyrosine phosphorylation was substantially attenuated (11) . Finally, although significantly slowed, GH-induced GHR disulfide linkage still proceeded at 4°C (12) .
Our current studies substantiated further the conclusion that GHR disulfide linkage is a reflection of receptor dimerization. The GH concentration dependences for GHR disulfide linkage and loss of anti-GHR ext precipitability are quite similar, indicating that these two phenomena may share underlying determinants. Furthermore, G120K could not support GHR disulfide linkage and antagonized the ability of GH to promote this linkage at G120K:GH ratios that also reverse the loss of anti-GHR ext precipitability and have previously been shown to antagonize GH-induced biological activities (10, 27, 29) . Notably, GH induced receptor disulfide linkage of both mouse (3T3-F442A cells) and rabbit (transiently and stably transfected into COS-7 and CHO cells, respectively) GHRs, indicating that this phenomenon is generally found among various species; G120K also antagonized GH-induced GHR disulfide linkage in 3T3-F442A cells.
Although GH-induced GHR disulfide linkage reflects GHR dimerization, we were able to uncouple the two phenomena. Our mutagenesis results strongly point to cysteine 241 as critical in formation of the disulfide-linked receptor; mutation to serine rendered the rabbit GHR incapable of efficiently undergoing this linkage. Yet, consistent with studies showing a lack of impairment of receptor extracellular domain folding when residue 241 was mutated (30) , rGHR C241S displayed a capacity for 125 I-hGH binding similar to that seen for the wild-type rGHR when each was expressed in COS-7 cells. Our use of anti-GHR ext immunoprecipitation as a monitor of GH-induced dimerization indicated that, despite its inability to become disulfide-linked in response to GH, rGHR C241S still under- rabbit GHR are bracketed. Note the slight retardation of migration of monomeric GHRs under both reducing and nonreducing conditions in response to GH (lanes 3, 5, and 6), consistent with GH-induced tyrosine phosphorylation of the GHR (see B and C). B, GH-induced tyrosine phosphorylation of JAK2. As described in A, the same pools of transfected cells were treated without (Ϫ) or with (ϩ) GH (500 ng/ml) for 10 min, as indicated. FLB extracts (one-half 150 ϫ 25-mm dish equivalent per condition) were immunoprecipitated (IP) with anti-JAK2 AL33 (lanes 1-5) or nonimmune (NI) serum (lane 6), resolved by SDS-PAGE under reducing conditions, and sequentially immunoblotted with anti-JAK2 AL33 (upper panel) and antiphosphotyrosine (APT) antibody (middle panel). The positions of JAK2 and tyrosine-phosphorylated JAK2 (P-JAK2) are indicated. Specific JAK2 tyrosine phosphorylation induced by GH was densitometrically determined from the data in the upper and middle panels of this experiment, as detailed under "Experimental Procedures." The GH-induced fold increase in specific JAK2 tyrosine phosphorylation for both WT rGHR and rGHR C241S is graphically displayed in the lower panel. Note that GH-induced tyrosine phosphorylation of JAK2 is not prevented by expression of rGHR C241S, although rGHR C241S does not undergo disulfide linkage. C, GH-induced tyrosine phosphorylation of WT rGHR and rGHR C241S and the GH-induced enhancement of coimmunoprecipitation of JAK2 with each receptor. The same extracts as those used in A and B were subjected to anti-GHR cyt-AL37 immunoprecipitation and eluates were resolved under reducing conditions and sequentially immunoblotted with anti-GHR cyt , APT antibody, and anti-JAK2 AL33 . Graphically displayed are the relative specific GHR tyrosine phosphorylations induced by GH for WT rGHR and rGHR C241S (upper panel) and the relative GH-induced enhancements in the levels of JAK2 coimmunoprecipitated with GHR form (lower panel) in this experiment, in each case estimated as detailed under "Experimental Procedures." Note that neither GHinduced tyrosine phosphorylation of GHR nor GH-induced enhancement of GHR-JAK2 association is prevented by expression of rGHR C241S. The experiments shown in A-C are representative of two such experiments.
went GH-induced dimerization (anti-GHR ext precipitation of rGHR C241S was substantially decreased by GH treatment). These findings favor a model in which GH promotes rapid noncovalent receptor dimerization which then quickly progresses to a disulfide-linked assembly of receptor dimers if cysteine 241 is intact. Our results indicate that receptor dimerization is not driven by disulfide linkage, but they do not rule out the possibility that covalent receptor dimers may display enhanced stability; this issue is worthy of further study.
Since GHR dimerization has been amply shown to be required for GH-induced signaling, we used these two monitors of GHR dimerization (loss of anti-GHR ext precipitability and GHR disulfide linkage) to probe the mechanism(s) underlying the GH-induced enhancement of association of GHR and JAK2 that we and others (7, 15, 20) have observed in various cell types. By using 3T3-F442A cells, we found that GH treatment enhanced the coimmunoprecipitation of JAK2 (including tyrosine phosphorylated JAK2) with anti-GHR antibodies directed at the receptor cytoplasmic domain, but that G120K did not promote such enhancement and antagonized GH in this respect. These findings indicate that occupancy of the monomeric GHR (as occurs with G120K treatment) is not sufficient to promote enhanced GHR-JAK2 association and are consistent with GHR dimerization, per se, being potentially important in augmenting interaction with JAK2.
However, because dimerization is a proximal event in GH signaling, it is also conceivable that GHR-JAK2 association becomes more detectable as a consequence of activation of GH signaling pathway(s), rather than because of the bringing together of receptor cytoplasmic domains. Whereas we cannot yet rule out that a signaled event, rather than receptor dimerization, drives the enhanced association with JAK2, the results of the experiments in which GH-induced tyrosine phosphorylation of GHR and JAK2 is either dramatically less well preserved during anti-GHR cyt-AL37 precipitation (by omitting orthovanadate from the harvesting buffer) or is significantly prevented (by staurosporine pretreatment) are instructive. In each instance, GH-induced enhancement of JAK2 coimmunoprecipitation with GHR was unaffected. Since tyrosine phosphorylation of GHR and JAK2 is believed to influence signaling at least in part by facilitating phosphotyrosine-dependent recruitment of other molecules to the GHR-JAK2 signaling complex (2, 3, 31, 32) , these results further argue against molecules recruited in such a manner being the "glue" that strengthens GHR-JAK2 association. However, as we have recently demonstrated (33) for JAK2 and IRS-1, some signaling molecules that become activated by GH are likely associated to some degree with JAK2 and possibly GHR prior to GH stimulation; we cannot yet know whether such associated proteins might bridge GHR and JAK2 in response to GH.
We note that in our prior work, bacterially expressed GST fusion proteins incorporating Box 1-containing elements of the GHR cytoplasmic domain specifically interacted with JAK2 in detergent extracts from eukaryotic cells independent of prior GH treatment of those cells (15) . This finding supports the contention that activation-dependent effects are not required for GHR-JAK2 association. Given our current findings that GHR dimerization, as such, might influence association with JAK2, it is interesting to note that GST fusion proteins, by virtue of the propensity of GST to form disulfide-linked dimers, might be significantly dimerized when used in affinity precipitation experiments such as those described (34, 35) . 2 We do not yet know whether such dimerization might have allowed enhanced association of the GST/GHR fusion proteins with JAK2. Given that we have been able to coimmunoprecipitate specifically JAK2 with anti-GHR cyt antiserum from IM-9 cells not treated with GH (though always less than that seen after GH exposure) (15) , we favor a model in which GHR and JAK2 are associated in the absence of GH but that the association is strengthened by GH treatment such that the receptor/JAK2 assemblage is more apt to remain intact during detergent extraction and immunoprecipitation. Although our experiments with rGHR C241S indicate that receptor disulfide linkage is not necessary to sustain GH-enhanced GHR-JAK2 interaction, our working hypothesis is that dimerized receptor cytoplasmic domains either interact more avidly with associated JAK2 molecules or that signaling complexes with increased JAK2⅐GHR stoichiometry are promoted by GH treatment. Discrimination   FIG. 9 . Acute GH-induced tyrosine phosphorylation of STAT5 is similar in CHO-rGHR and CHO-rGHR C241S cells. A, lack of GH-induced disulfide linkage of rGHR C241S. CHO-rGHR and CHOrGHR C241S cells were generated as described under "Experimental Procedures." Cells were treated without (Ϫ) or with (ϩ) GH (500 ng/ml) for 1 min, as indicated. FLB extracts (one-half 100 ϫ 20-mm dish equivalent per condition) were resolved by SDS-PAGE under nonreducing conditions. GHRs were detected by anti-GHR cyt-AL37 immunoblotting (WB). The positions of the monomeric and disulfide-linked (dsl) rabbit GHR are bracketed. The experiment shown is representative of five such experiments. B, GH-induced enhancement of coimmunoprecipitation of JAK2 with the GHR in CHO-rGHR and CHO-rGHR C241S cells. The same extracts as those used in A were subjected to anti-GHR cyt-AL37 immunoprecipitation (IP). Eluates were resolved under reducing conditions and sequentially immunoblotted with anti-GHR cyt-AL37 (upper panel) and anti-JAK2 AL33 (lower panel). The positions of the immunoprecipitated rGHR and JAK2 are indicated. Note the slight retardation of migration of GHRs in response to GH (lanes 2 and 4), indicative of the GH-induced tyrosine phosphorylation of the GHR. C, GH time and concentration dependence of tyrosine phosphorylation of STAT5 in CHO-rGHR and CHO-rGHR C241S cells. Cells were treated with vehicle (0) or GH (500 ng/ml) for the indicated duration (upper panel) or for 10 min at the indicated GH concentration (lower panel). Total cell extracts were resolved by SDS-PAGE under reducing conditions and immunoblotted with anti-phospho-STAT5. The position of the tyrosine-phosphorylated STAT5 (P-STAT5) is indicated.
